Aug 16, 2018 | Featured Insights
Last week, Baron & Budd’s lawyers secured $90 million from AstraZeneca in a resolution that the pharmaceutical company targeted the Texas Medicaid system with a fraudulent marketing scheme for its expensive and powerful atypical antipsychotic drugs Seroquel IR and... 
Aug 14, 2018 | Featured Insights
A notable settlement with big pharma was reached last week. Joel M. Androphy and Sarah M. Frazier of Berg & Androphy, along with the State of Texas and other law firms, reached settlements in Texas Medicaid Fraud Prevention Act litigation against AstraZeneca. This...